2024-03-28 20:52:08 ET
Pulse Biosciences Inc (PLSE)
Q4 2023 Results Conference Call
March 28, 2024 4:30 PM ET
Company Participants
Philip Taylor - IR
Kevin Danahy - President & CEO
Darrin Uecker - CTO & Director
Mitch Levinson - Chief Strategy Officer
Mike Koffler - Vice President of Finance
Bob Duggan - Executive Chairman
Conference Call Participants
Brad Bowers - Mizuho Securities
Presentation
Operator
Greetings, and welcome to the Pulse Biosciences Fourth Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Philip Taylor, Investor Relations. Thank you, sir. You may begin.
Philip Taylor
Thank you, operator. Before we begin, I would like to inform you that comments and responses to your questions during today's call reflect management's views as of today, March 28, 2024 only and will include forward-looking statements and opinion statements, including predictions, estimates, plans, expectations and other similar information.
Actual results may differ materially from those expressed or implied as a result of certain risks and uncertainties. These risks and uncertainties are more fully described in our press release issued earlier today and in our filings with the U.S. Securities and Exchange Commission. Our SEC filings can be found on our website or on the SEC's website. Investors are cautioned not to place undue reliance on forward-looking statements. We disclaim any obligation to update or revise these forward-looking statements....
Read the full article on Seeking Alpha
For further details see:
Pulse Biosciences Inc (PLSE) Q4 2023 Earnings Call Transcript